Skip to content

Clinical trials

Phase 1/2 Leukemia, Lymphocytic, Chronic, B-Cell trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 1/2 Country / region: Spain Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20153
20181
20191
20202
20212
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Active, not recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genmab3
AstraZeneca2
Advancell - Advanced In Vitro Cell Technologies, S.A.1
Aptevo Therapeutics1
BeOne Medicines1
Celgene1
Genentech, Inc.1
Hospital Universitari Vall d'Hebron Research Institute1
IDP Discovery Pharma S.L.1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell15
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, Mantle-Cell4
Lymphoma, Non-Hodgkin4
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Follicular3
Recurrence3
Leukemia2
Leukemia, B-Cell2
Lymphoma, B-Cell2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.